Catheter Precision, Inc. (VTAK) has 2,692,473 shares outstanding and a cash runway of 0.3 months. The company has no ATM or shelf capacity remaining. Its public float of 2,289,356 shares is under 12.7% short interest. The dilution overhang is 895.5% of the float.
The core risk thesis is clear: the company is in a dire liquidity position, with no remaining capital-raising capacity. The shelf registration capacity is $0, yet the company has 20,502,073 warrants outstanding, equal to 761.5% of shares outstanding. The 895.5% dilution overhang is a direct threat to existing shareholders. The company is in a position where it must raise capital immediately, and the market has no capacity to absorb new shares without severe dilution.
The scale of potential dilution is extreme. With a cash runway of 0.3 months, the company has no time to wait for a favorable market. The 895.5% dilution overhang is well above the typical range for most companies, which rarely exceed 100% dilution. This is not a company with a balanced capital structure. It is a company on the edge, with a public float that is not equipped to handle the existing warrant and convertible overhang.
The company has filed four dilution events in the past 12 months, including an S-1 and S-1/A. The share count has grown by 5,919.3% over three years, a rate that is unsustainable and indicative of a company in crisis. The management team has no option but to raise capital, and the cash runway of 0.3 months means the window is closing quickly.
That math is brutal.
The shelf registration capacity is $0, but the company has a massive dilution overhang of 895.5% of the float. This means that if all warrants and convertibles were exercised, the share count would multiply nearly nine times. In comparison, most companies with a dilution overhang above 500% are considered high risk. VTAK is not just high risk — it is a near-certainty of dilution.
The market cap of VTAK is not provided, but the 895.5% overhang is so large that it suggests a potential dilution of more than 8x the current float. This is not typical of a healthy company. It is the result of a capital structure that is fundamentally broken. The company has not raised capital in a way that preserves existing shareholder value. It has raised capital through warrants and convertibles that have a severe impact on ownership.
The pattern repeats.
With a cash runway of 0.3 months, the urgency for capital is immediate. The company has no remaining ATM or shelf capacity, so it must raise capital through other means. The recent 424B3 filing suggests that the company is preparing for a capital raise, possibly through a direct offering or a private placement. The lack of available capital-raising tools means that the company may have to accept unfavorable terms.
The 424B3 filing in late June 2026 suggests that the company is preparing for a capital raise. The short cash runway of 0.3 months means that the company has no time to wait for a favorable market. It will raise capital as soon as possible, regardless of the terms. The management team is likely under pressure to secure funding at any cost, which could lead to a significant dilution event.
Watch the cash, not the price.
The company has filed four dilution events in the past 12 months, including two S-1 filings and two 424B3s. This is a clear pattern of serial dilution. The share count has grown by 5,919.3% over three years, a rate that is not sustainable. This growth suggests that the company has been raising capital through dilutive instruments rather than through profitable operations.
The 5,919.3% share count growth is a red flag. It indicates that the company has been raising capital at a rate that is far higher than the industry standard. This is not a company that is growing organically — it is a company that is relying on dilution to fund operations. The repeated filings suggest that the company is in a cycle of fundraising that has become a necessity rather than an option.
The pattern repeats.
The DilutionWatch score of 88/100 is driven by the high offering ability (80/100) and warrant risk (90/100). The company has a massive warrant overhang of 761.5% of shares outstanding, which is a direct threat to existing shareholders. The warrant risk score of 90/100 reflects the high potential for dilution from these instruments.
The float risk is 35/100, which is low compared to other categories, but this is because the float is already highly diluted. The company has a public float of 2,289,356 shares, but the 895.5% dilution overhang means that the float is not a reliable measure of liquidity. The convertible risk is 40/100, which is low because there are no convertible shares currently outstanding.
The score penalty of -15 points for repeat dilution is well-justified. The company has filed four dilution events in the past 12 months, which is a clear sign of a problematic capital structure.
That math is brutal.
If the company raises $20M at market price before the ATM is triggered, the dilution would be catastrophic. The public float is 2,289,356 shares, and a $20M raise at $1 per share would add 20 million new shares — a 873% increase to the float. This would be a liquidity crisis for existing shareholders.
If the company fails to secure capital before its cash runway expires, it may be forced to file for bankruptcy or a restructuring. The lack of shelf capacity and the short cash runway make this a real possibility. The market has no time to react, and the company has no option but to raise capital immediately.
The most immediate trigger is the company's cash balance dropping below 0.3 months. If the cash runway shrinks further, the company will have no choice but to raise capital immediately. The recent 424B3 filing suggests that the company is preparing for a capital raise, and the lack of shelf capacity means it will have to act quickly.
Another key trigger is the company's stock price. If the stock falls below a certain level, the company may be forced to issue more shares at a discount, leading to further dilution. The 12.7% short interest means that the stock is already under pressure, and a drop in price could trigger a cascade of selling.
Watch for an S-3 drawdown within 90 days if the stock price holds above $0.10.
My read: This is a high-risk stock with a severe dilution problem. The single most important trigger to watch in the next 30-60 days is the company’s cash runway dropping below 0.1 months. If that happens, the risk of a dilutive capital raise is near certainty.
DilutionWatch monitors shelf registrations, ATM offerings, warrant exercises, and cash runway across thousands of public companies — updated daily from SEC filings.
Get Full Access — Free Trial →